Correlation between plasma total nitric oxide levels and cerebral vasospasm and clinical outcome in patients with aneurysmal subarachnoid hemorrhage in Indian population

Journal of Neurosciences in Rural Practice

Volumn 5, Issue 5, 2014, Pages S22-S27

  Ramesh, Shruthi Shimoga ^a   Prasanthi, Aripirala ^a   Bhat, Dhananjaya Ishwar ^a   Devi, Bhagavatula Indira ^a   Cristopher, Rita ^a   Philip, Mariamma ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Aneurysmal subarachnoid hemorrhage; cerebral vasospasm; nitric oxide; poor outcome

Indexed keywords

NITRATE; NITRIC OXIDE; NITRITE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BRAIN VASOSPASM; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLASGOW COMA SCALE; HUMAN; HYPERTENSION; INCIDENCE; INDIAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; SMOKING; SUBARACHNOID HEMORRHAGE; TERTIARY CARE CENTER; WORLD FEDERATION OF NEUROSURGEONS GRADING SCALE;

EID: 84914115512     PISSN: 09763147     EISSN: 09763155     Source Type: Journal    
DOI: 10.4103/0976-3147.145196     Document Type: Article

References (36)

1. Perazella MA, Tofteland ND, Salyers Jr. WJ. Subarachnoid Haemorrhage. Hosp Physician 2007;43:31-41.
2. Kolias AG, Sen J, Belli A. Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid haemorrhage: Putative mechanisms and novel approaches. J Neurosci Res 2009;87:1-11.
3. Sercombe R, Dinh YR, Gomis P. Cerebrovascular inflammation following subarachnoid haemorrhage. Jpn J Pharmacol 2002;88:227-49.
4. Kozniewska E, Michalik R, Rafalowska J, Gadamski R, Walski M, Frontczak-Baniewicz M, et al. Mechanisms of vascular dysfunction after subarachnoid haemorrhage. J Physiol Pharmacol 2006;57 Suppl 11:145-60.
5. Pickard JD, Walker V, Brandt L, Zygmunt S, Smythe J. Effect of intraventricular haemorrhage and rebleeding following subarachnoid haemorrhage on CSF eicosanoids. Acta Neurochir (Wien) 1994;129:152-7.
6. Hirashima Y, Endo S, Kato R, Takaku A. Prevention of cerebrovasospasm following subarachnoid haemorrhage in rabbits by the platelet-Activating factor antagonist, E5880. J Neurosurg 1996;84:826-30.
7. Kessler IM, Pacheco YG, Lozzi SP, de Araújo AS Jr, Onishi FJ, de Mello PA. Endothelin-1 levels in plasma and cerebrospinal fluid of patients with cerebral vasospasm after aneurysmal subarachnoid haemorrhage. Surg Neurol 2005;64 Suppl 1:S1-5 discussion S1:5.
8. Hansen-Schwartz J. Cerebral vasospasm: A consideration of the various cellular mechanisms involved in the pathophysiology. Neurocrit Care 2004;1:235-46.
9. Zimmermann M, Seifert V. Endothelin and subarachnoid haemorrhage: An overview. Neurosurgery 1998;43:863-76.
10. Sehba FA, Schwartz AY, Chereshnev I, Bederson JB. Acute decrease in cerebral nitric oxide levels after subarachnoid haemorrhage. J Cereb Blood Flow Metab 2000;20:604-11.
11. Kasuya H, Weir BK, Nakane M, Pollock JS, Johns L, Marton LS, et al. Nitric oxide synthase and guanylate cyclase levels in canine basilar artery after subarachnoid haemorrhage. J Neurosurg 1995;82:250-5.
12. Moncada S, Palmer RM, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42.
13. Pluta RM, Oldfield EH. Analysis of nitric oxide (NO) in cerebral vasospasm after aneursymal bleeding. Rev Recent Clin Trials 2007;2:59-67.
14. Afshar JK, Pluta RM, Boock RJ, Thompson BG, Oldfield EH. Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid haemorrhage. J Neurosurg 1995;83:118-22.
15. Ryba MS, Gordon-Krajcer W, Walski M, Chalimoniuk M, Chrapusta SJ. Hydroxylamine attenuates the effects of simulated subarachnoid haemorrhage in the rat brain and improves neurological outcome. Brain Res 1999;850:225-33.
16. Pluta RM, Afshar JK, Thompson BG, Boock RJ, Harvey-White J, Oldfield EH. Increased cerebral blood flow but no reversal or prevention of vasospasm in response to L-Arginine infusion after subarachnoid haemorrhage. J Neurosurg 2000;92:121-6.
17. Titheradge MA. The enzymatic measurement of nitrate and nitrite. In: Titheradge MA, editor. Chapter 9: Methods in Molecular Biology. Totowa, New Jersey: Humana Press Inc; 1997. p. 83-91.
18. Harrod CG, Bendok BR, Batjer HH. Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid haemorrhage: A review. Neurosurgery 2005;56:633-54.
19. Haley EC Jr, Kassell NF, Torner JC. The international cooperative study on the timing of aneurysm surgery. The North American experience. Stroke 1992;23:205-14.
20. Kassell NF, Sasaki T, Colohan AR, Nazar G. Cerebral vasospasm following aneurysmal subarachnoid haemorrhage. Stroke 1985;16:562-72.
21. Frontera JA, Fernandez A, Schmidt JM, Claassen J, Wartenberg KE, Badjatia N, et al. Defining vasospasm after subarachnoid haemorrhage: What is the most clinically relevant definition? Stroke 2009;40:1963-8.
22. Suhardja A. Mechanisms of disease: Roles of nitric oxide and endothelin-1 in delayed cerebral vasospasm produced by aneurysmal subarachnoid haemorrhage. Nat Clin Pract Cardiovasc Med 2004;1:110-6.
23. Macdonald RL, Weir BK. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 1991;22:971-82.
24. Zubkov AY, Ogihara K, Bernanke DH, Parent AD, Zhang J. Apoptosis of endothelial cells in vessels affected by cerebral vasospasm. Surg Neurol 2000;53:260-6.
25. Martens-Lobenhoffer J, Sulyok E, Czeiter E, Büki A, Kohl J, Firsching R, et al. Determination of cerebrospinal fluid concentrations of arginine and dimethylarginines in patients with subarachnoid haemorrhage. J Neurosci Methods 2007;164:155-60.
26. Sakowitz OW, Wolfrum S, Sarrafzadeh AS, Stover JF, Dreier JP, Dendorfer A, et al. Relation of cerebral energy metabolism and extracellular nitrite and nitrate concentrations in patients after aneurysmal subarachnoid haemorrhage. J Cereb Blood Flow Metab 2001;21:1067-76.
27. Durmaz R, Ozkara E, Kanbak G, Arslan OC, Dokumacioʇlu A, Kartkaya K, et al. Nitric oxide level and adenosine deaminase activity in cerebrospinal fluid of patients with subarachnoid haemorrhage. Turk Neurosurg 2008;18:157-64.
28. Woszczyk A, Deinsberger W, Böker DK. Nitric oxide metabolites in cisternal CSF correlate with cerebral vasospasm in patients with a subarachnoid haemorrhage. Acta Neurochir (Wien) 2003;145:257-64.
29. Fathi AR, Pluta RM, Bakhtian KD, Qi M, Lonser RR. Reversal of cerebral vasospasm via intravenous sodium nitrite after subarachnoid haemorrhage in primates. J Neurosurg 2011;115:1213-20.
30. Pluta RM, Dejam A, Grimes G, Gladwin MT, Oldfield EH. Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid haemorrhage. JAMA 2005;293:1477-84.
31. Kumar R, Pathak A, Mathuriya SN, Khandelwal N. Intraventricular sodium nitroprusside therapy: A future promise for refractory subarachnoid haemorrhage-induced vasospasm. Neurol India 2003;51:197-202.
32. Kiriş T, Karasu A, Yavuz C, Erdem T, Unal F, Hepgül K, et al. Reversal of cerebral vasospasm by the nitric oxide donor SNAP in an experimental model of subarachnoid haemorrhage. Acta Neurochir (Wien) 1999;141:1323-9.
33. Ko NU, Rajendran P, Kim H, Rutkowski M, Pawlikowska L, Kwok PY, et al. Endothelial nitric oxide synthase polymorphism (-786T-C) and increased risk of angiographic vasospasm after aneurysmal subarachnoid haemorrhage. Stroke 2008;39:1103-8.
34. Starke RM, Kim GH, Komotar RJ, Hickman ZL, Black EM, Rosales MB, et al. Endothelial nitric oxide synthase gene single-nucleotide polymorphism predicts cerebral vasospasm after aneurysmal subarachnoid haemorrhage. J Cereb Blood Flow Metab 2008;28:1204-11.
35. Jung CS, Lange B, Zimmermann M, Seifert V. The CSF concentration of ADMA, but not of ET-1, is correlated with the occurrence and severity of cerebral vasospasm after subarachnoid haemorrhage. Neurosci Lett 2012;524:20-4.
36. Jung CS, Iuliano BA, Harvey-White J, Espey MG, Oldfield EH, Pluta RM. Association between cerebrospinal fluid levels of asymmetric dimethyl-L-Arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid haemorrhage. J Neurosurg 2004;101:836-42.